Funding Opportunities

NIH-funded research has led to breakthroughs and the development of new treatments, helping people live longer, healthier lives and building the research foundation that drives discovery. ORWH publishes and participates in various NIH funding opportunity announcements (FOAs) that seek to advance the science on the health of women. This page includes a curated selection of funding opportunities supporting maternal health research at both the NIH and broader U.S. Department of Health and Human Services. This list of FOAs is not exhaustive but is updated on a regular basis to include funding opportunities from the sources mentioned above. For additional NIH-related funding opportunity information, you may visit the NIH Funding Opportunities page.

The following funding opportunities can be sorted across each column header. Click the specific column heading in the table to modify how the information is listed.

TitleAnnouncement NumberIssuing OrganizationOpening DateClosing Date  
Women's Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial Optional)RFA-HD-25-005NICHD7/19/202411/16/2024  
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)RFA-DA-25-021NIDA10/30/202311/16/2024  
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)RFA-OD-22-028ORWH10/13/202211/23/2024  
Solutions to Enable Diagnosis and Treatment of Adverse Health Consequences of Non-Disordered Drug Use (R41/R42 - Clinical Trial Optional)RFA-DA-25-049NIH-NIAID6/13/202412/3/2024  
Solutions to Enable Diagnosis and Treatment of Adverse Health Consequences of Non-Disordered Drug Use (R43/R44 - Clinical Trial Optional)RFA-DA-25-050NIH-NIAID6/13/202412/3/2024  
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)PAR-23-180NIH11/7/202312/8/2024  
Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)RFA-HD-25-003NICHD8/16/202412/12/2024  
Partnership for National Maternal and Child Health (MCH) LeadershipHRSA-25-028HRSA10/3/20241/3/2025  
Maternal and Child Health Public Health Catalyst ProgramHRSA-25-025HRSA10/25/20241/23/2025  
Centers of Excellence in Maternal and Child Health Education, Science, and PracticeHRSA-25-027HRSA10/28/20241/27/2025  
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)RFA-AA-24-006NIH, NIAAA, NINR, NIMHD3/6/20242/20/2025  
Notice of Special Interest (NOSI): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiativeNOT-HD-22-043NICHD9/22/20225/7/2025  
Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)PAR-21-358NIMHD5/5/20225/8/2025  
U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)RFA-AI-24-023NIAID9/17/20245/12/2025  
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)PAR-25-146HHS/NIH11/6/20249/7/2025  
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH)NSF 23-614NSF and NIHN/A10/3/2025  
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)PAR-24-256NICHD7/12/202411/17/2025  
Notice of Special Interest: Tools to Enhance the Study of Prenatal and Pediatric HydrocephalusNOT-NS-23-003NINDS5/20/202212/10/2025  
Notice of Special Interest: Disease Mechanisms of Prenatal and Pediatric HydrocephalusNOT-NS-23-004NINDS5/20/202212/10/2025  
Notice of Special Interest : Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)NOT-OD-24-179ORWH10/11/20241/23/2026  
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)PAR-24-118NIMH; NIDA5/16/20241/8/2026  
Notice of Special Interest (NOSI): Maternal Health and the Dental, Oral, and Craniofacial Development of their ChildrenNOT-DE-23-005NIDCR8/2/20233/17/2026  
Notice of Special Interest (NOSI): Administrative Supplements to Leverage Network Infrastructure to Advance Multisite Research for Women, Children, Pregnant and Lactating Individuals and/or Persons with DisabilitiesNOT-HD-23-005NICHD, ORWH2/27/20234/1/2026  
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)PAR-23-037NICHD11/28/20225/7/2026  
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)PAR-23-130NICHD3/1/20235/8/2026  
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)PAR-23-131NICHD3/1/20235/8/2026  
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal HealthNOT-EB-23-005NIH9/5/20239/6/2026  
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)PAR-23-295NHGRI10/30/202311/17/2026  
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)PAR-24-068NIAAA11/22/202311/17/2026  
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)PAR-23-293NHGRI10/30/202311/19/2026  
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)PAR-23-294NHGRI10/30/202311/19/2026  
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)PAR-24-059NIH1/5/20241/8/2027  
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)PAR-24-067NIAAA11/22/20231/8/2027  
Notice of Special Interest: Women’s Health ResearchNOT-OD-24-079NIH5/6/202411/5/2027  
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)PAR-25-227HHS/NIH11/6/20241/7/2028  
Notice of Special Interest (NOSI): Consequences of Prenatal Fentanyl ExposureNOT-DA-26-003NIDA9/13/20249/8/2028  
Research to Advance the Science of Primary Care (R01)PA-24-205AHRQ4/3/202411/6/2029  
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)PAR-21-098NIAAA12/11/2020MANY  
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)PAR-21-097NIAAA12/11/2020MANY  
Notice of Early Expiration of NOT-HD-22-043 "Notice of Special Interest ( NOSI ): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE Initiative"NOT-HD-23-008NICHD3/28/2023n/a  
Notice of Special Interest (NOSI): Advancing Research on Early Pregnancy LossNOT-HD-22-026NICHD7/5/2022n/a  
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)NOT-OD-22-174NICHD7/6/2022n/a  
Notice of Intent to Publish a Funding Opportunity Announcement for Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)NOT-OD-22-171NICHD7/6/2022n/a  
Notice of Training and REDCap Demonstration for the Implementation of NICHD's CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) PortalNOT-HD-22-047NICHD10/5/2022n/a  
Notice of NINR Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health"NOT-NR-23-003NINR11/28/2022n/a